Microarray Analyses
Showing 26 - 50 of 3,274
Genetic and Epigenetic Factors on Clinical Response and Toxicity
Recruiting
- Breast Cancer
-
Cairo, EgyptAin Shams University
Feb 8, 2023
Pancreatic Injury and Corresponding Management Outcome (PICO)
Recruiting
- Trauma
- Standard treatment
-
Nanjing, Jiangsu, ChinaJinling Hospital
Jan 11, 2022
Infertility, Intellectual Disability, Malformation Trial (Optical Genome Mapping (Bionano®), Longread sequencing (Nanopore®))
Not yet recruiting
- Infertility
- +2 more
- Optical Genome Mapping (Bionano®)
- Longread sequencing (Nanopore®)
- (no location specified)
Mar 11, 2022
Natural History Study for BEN
Completed
- Neutropenia
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2020
Prosigna Assay on Neoadjuvant Clinical Decision-making in
Recruiting
- Breast Cancer
- Prosigna PAM-50 assay
-
Boston, MassachusettsDana-Farber Cancer Institute
Apr 5, 2022
Idiopathic Pulmonary Fibrosis (IPF)
Active, not recruiting
- Pulmonary Fibrosis
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Dec 13, 2022
Colorectal Cancer, Cardiovascular Diseases, Type2 Diabetes Trial in Helsinki (Partial replacement of red meat with legume-based
Active, not recruiting
- Colorectal Cancer
- +2 more
- Partial replacement of red meat with legume-based foods
-
Helsinki, FinlandDepartment of Food and Nutrition, University of Helsinki
May 17, 2022
Gene Mutations in Triple-negative and HER2+ Breast Cancer
Active, not recruiting
- Breast Cancer
-
Athens, GreeceGeorge Fountzilas
Mar 15, 2022
Metabolic Syndrome, Vascular Compliance, Predisposition to Cardiovascular Disease Trial in Clermont-Ferrand (Beverage
Recruiting
- Metabolic Syndrome
- +2 more
- Beverage consumption
-
Clermont-Ferrand, Aura, FranceUniversity Hospital, Clermont Ferrand
Jun 30, 2022
Breast Tumor Female Trial in Netherlands (CDK 4/6 inhibitor, Non-Steroidal Aromatase Inhibitor, Fulvestrant)
Active, not recruiting
- Breast Neoplasm Female
- CDK 4/6 inhibitor
- +2 more
-
Alkmaar, Netherlands
- +71 more
Apr 1, 2022
Thyroid Cancer Trial in Toulouse, Montpellier (Signature of 10 microRNA for patients with bethesda classification 3, 4 or 5)
Recruiting
- Thyroid Cancer
- Signature of microRNA for patients with bethesda classification 3, 4 or 5
-
Toulouse, Haute-Garonne, France
- +1 more
Jan 13, 2023
Duration of Silicone Oil Tamponade on Foveal and Parafoveal
Completed
- Retinal Detachment
- Silicone oil Tamponade for Retinal Detachment
-
Cairo, EgyptKasr alainy faculty of medicine
Apr 17, 2023
Multiplex PCR -Microarray-based Assay in Detection of
Completed
- Tuberculosis
- Non-Tuberculous Mycobacterial Pneumonia
- VereMTB
-
Sha Tin, Hong KongPrince of Wales Hospital
Aug 7, 2022
Study of Sperm Molecular Factors Implicated in Male Fertility
Completed
- Male Infertility
- Microarray analysis
- Microarray
-
Valencia, SpainInstituto Universitario Ivi
Mar 31, 2022
Androgenetic Alopecia Trial in Cleveland (Minoxidil, Placebo)
Completed
- Androgenetic Alopecia
- Minoxidil
- Placebo
-
Cleveland, OhioSkin Study Center, UH Case Medical Center
Apr 28, 2022
COVID RESPONSE STUDY (COVRES)
Completed
- COVID-19
- Disease severity
-
Londonderry, United KingdomPersonalised Medicine Centre, School of Medicine, Ulster Univers
Sep 20, 2022
Hepatocellular Carcinoma Trial (Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle)
Not yet recruiting
- Hepatocellular Carcinoma
- Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle
- (no location specified)
Jun 12, 2023
Metabolic Syndrome, HEALTHY VOLUNTEERS, Time Restricted Feeding Trial in Amsterdam (Time Restricted Eating, normal diet)
Recruiting
- Metabolic Syndrome
- +4 more
- Time Restricted Eating
- normal diet
-
Amsterdam, NetherlandsAmsterdam UMC location AMC
Jun 1, 2023
Spastic Cerebral Palsy Trial in Leuven (Dietary Supplement: Leucine)
Recruiting
- Spastic Cerebral Palsy
- Dietary Supplement: Leucine
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
Sep 15, 2023
Hiv Trial in Thailand (In-depth interviews (IDI), Focus group discussion (FGD))
Not yet recruiting
- Hiv
- In-depth interviews (IDI)
- Focus group discussion (FGD)
-
Bangkok, Bangkapi, Thailand
- +11 more
Mar 7, 2023
Healthy Trial in Los Angeles (BFR, Stanard strengthening program.)
Recruiting
- Healthy
- BFR
- Stanard strengthening program.
-
Los Angeles, CaliforniaCedar Sinai Kerlan jobe orthopedic institute
May 10, 2023
Hypoxia, Altitude Trial in Cologne (Hypobaric Hypoxia)
Completed
- Hypoxia, Altitude
- Hypobaric Hypoxia
-
Cologne, North Rhine-Westphalia, GermanyUniversity Hospital Cologne
Oct 13, 2022
Biomarker-s of Abusive Head Trauma by Proteomics
Not yet recruiting
- Abuse, Child
- Protein Disorder, Blood
- Blood test
-
Lyon, Rhône, France
- +1 more
Jan 11, 2023
Polycystic Ovary, Progesterone Resistance Trial (Progesterone 400 Mg Vaginal Suppository on PCOS)
Completed
- Polycystic Ovary
- Progesterone Resistance
- Progesterone 400 Mg Vaginal Suppository on PCOS
- (no location specified)
Jan 4, 2022
Tomey OA-2000, Tomey CASIA2, and the LenStar LS900
Recruiting
- Cataract
- +2 more
- Optical measurement
-
Woburn, MassachusettsNorthEast Eye Research Associates
Sep 26, 2023